Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
11/2012
11/22/2012WO2012156948A1 Organic semiconductor material
11/22/2012WO2012156500A1 Semiconducting compound for gas sensing
11/22/2012WO2012156377A1 Stepwise assembled capture compounds and method for isolating proteins from complex mixtures
11/22/2012WO2012156022A1 Conjugated polymers
11/22/2012WO2012115394A3 Compound, organic electronic device using same, and electronic device thereof
11/22/2012US20120295965 Fused thiophenes as dual inhibitors of egfr/vegfr and their use in the treatment of cancer
11/22/2012US20120295946 Agents Useful for Reducing Amyloid Precursor Protein and Treating Dementia and Methods of Use Thereof
11/22/2012US20120295924 Thienopyrimidinedione derivatives as trpa1 modulators
11/22/2012US20120295900 1,3-oxazines as bace 1 and/or bace2 inhibitors
11/22/2012US20120295897 Spiro-oxindole compounds and their uses as therapeutic agents
11/22/2012US20120295882 Tricyclic Derivatives and Their Pharmaceutical Use and Compositions
11/22/2012US20120295318 Cyclopropenones and the photochemical generation of cyclic alkynes therefrom
11/22/2012CA2835835A1 Pyrrolidinyl urea and pyrrolidinyl thiourea compounds as trka kinase inhibitors
11/22/2012CA2835436A1 Parasiticidal dihydroisoxazole compounds
11/21/2012EP2524229A1 Method for preparing polybiotinylated compounds
11/21/2012CN102786532A Sulfur heterocyclic compound and preparation process thereof
11/21/2012CN102786531A Method for synthesizing d-biotin by catalytic double debenzylation
11/21/2012CN102786508A Spiro-fluorene-9,9-xanthene bipolar luminescent material, its preparation method and its application method
11/21/2012CN102786482A Akt蛋白激酶抑制剂 Akt protein kinase inhibitor
11/21/2012CN102391283B Clopidogrel hydrogen sulfate compound and preparation method thereof
11/21/2012CN102127091B Heterocyclic ring-containing schiff base compound
11/20/2012US8314091 N-benzyl,N'-arylcarbonylpiperazine derivatives
11/20/2012US8313902 Magnetic fine particles having lower critical solution temperature
11/20/2012US8313671 Heterocyclic compound and use thereof
11/20/2012CA2537559C Substituted piperidino phenyloxazolidinones having antimicriobial activity with improved in vivo efficacy
11/15/2012WO2012154009A2 Thienopyrimidine derivatives, pharmaceutically acceptable salts thereof, method for preparing thienopyrimidine derivatives, and pharmaceutical composition containing thienopyrimidine derivatives as active ingredients for preventing or treating diabetes-related diseases
11/15/2012WO2012153154A1 Oxetane substituted thieno pyrimidinones
11/15/2012WO2009052138A8 Preparation of dihydrothieno [3, 2-d] pyrimidines and intermediates used therein
11/15/2012US20120289702 Nitrogen-containing heterocyclic compound and agricultural fungicide
11/15/2012US20120289522 Compounds as lysophosphatidic acid receptor antagonists
11/15/2012US20120289501 Benzene-fused 6-membered oxygen-containing heterocyclic derivatives of bicyclic heteroaryls
11/15/2012US20120289474 3,4,4A,10B-TETRAHYDRO-1H-THIOPYRANO-[4,3-c] ISOQUINOLINE DERIVATIVES
11/15/2012US20120289471 Novel compounds with high therapeutic index
11/15/2012DE102011050363A1 Stufenweise aufbaubare Fängerverbindungen und Verfahren zur Proteinisolierung aus komplexen Gemischen Gradually erecting scavenger compounds and methods for protein isolation from complex mixtures
11/14/2012EP2522658A1 Nitrogen-containing heterocyclic compound and agricultural/horticultural germicide
11/14/2012EP2521549A1 Therapeutic compounds and related methods of use
11/14/2012CN102781945A Thienopyrazine compound and field effect transistor containing same
11/14/2012CN102775423A Method for preparing polymer monomer 3,4-ethylenedioxythiophene
11/14/2012CN102775422A Crystal form of Prasugrel intermediate
11/14/2012CN102775421A Hydrochloride of 2-hydroxy tetrahydrothienopyridine derivatives, and preparation method and medical application thereof
11/14/2012CN102775381A Substituted hydrazide compound, and its preparation method, medicinal compositions and application
11/14/2012CN101479276B Pharmaceutical compounds
11/13/2012US8309723 Preparation of Zopiclone and its enantiomerically enriched isomer
11/13/2012CA2518234C Thiolactones
11/10/2012CA2832202A1 Inhibitors of viral replication, their process of preparation and their therapeutical uses
11/08/2012WO2012150550A1 Novel pesticidal amino pyranone compounds
11/08/2012WO2012093809A3 New bicyclic compound for modulating g protein-coupled receptors
11/08/2012US20120283238 Irak inhibitors and uses thereof
11/07/2012EP2520571A1 2-azatriphenylene materials for organic light emitting diodes
11/07/2012EP2519527A1 Thieno [2,3-b]pyridinedione activators of ampk and therapeutic uses thereof
11/07/2012EP2519519A2 Substituted naphthalenyl-pyrimidine compounds
11/07/2012CN102770421A Orthoester derivatives of crown ethers as carriers for pharmaceutical and diagnostic compositions
11/07/2012CN102766142A Lactam compounds useful as protein kinase inhibitors
11/07/2012CN101687886B Compounds with 7-member cycle and the pharmaceutical use thereof for preventing and treating diabetes and metabolism syndrome
11/06/2012US8304414 Pyrazole compounds useful as protein kinase inhibitors
11/01/2012WO2012148889A1 Inhibitors of human apurinic/apyrimidinic endonuclease 1
11/01/2012WO2012148185A2 Organic semiconductor compound, method for preparing same, and organic semiconductor device employing same
11/01/2012WO2012145981A1 Adamantane or adamantane-like compounds as antitumor agents
11/01/2012WO2012100005A3 Synthetic transtaganolide and basiliolide products, derivatives thereof, and synthesis methods thereof
11/01/2012US20120277424 2,7-substituted thieno[3,2-d] pyrimidine compounds as protein kinase inhibitors
11/01/2012US20120277259 Substituted benzofused derivatives and their use as vanilloid receptor ligands
11/01/2012US20120277212 Novel Oxime Derivatives and Their Use As Allosteric Modulators of Metabotropic Glutamate Receptors
11/01/2012US20120277180 Cofactors and Methods for Use for Individuals
11/01/2012US20120276047 Fused tricyclic compounds and derivatives thereof useful for the treatment of viral diseases
10/2012
10/31/2012EP2518075A1 Induced layer material for preparing non-planar metal phthalocyanine weak epitaxy growth thin film
10/31/2012EP2518074A1 Phosphoinositide 3-kinase inhibitor compounds and methods of use
10/31/2012EP2516447A1 Process for preparing pharmaceutical compounds and intermediate compounds
10/31/2012CN102762575A Multicyclic compounds and methods of use thereof
10/31/2012CN102762574A Benzoxepin pi3k inhibitor compounds and methods of use
10/31/2012CN102757447A Urea transporter inhibitors, and preparation method and application thereof
10/30/2012US8299272 Process for production of fused ring compound
10/30/2012US8298512 Methods of determining β-III tubulin expression
10/30/2012CA2682504C Aurora kinase modulators and method of use
10/26/2012WO2012143080A2 Materials for organic electroluminescent devices
10/26/2012WO2012143077A1 Conjugated polymers
10/25/2012US20120271052 Electroluminescent thiophene derivatives
10/25/2012US20120270863 Fused ring analogues of anti-fibrotic agents
10/25/2012US20120270855 Thieno- and furo-pyrimidine modulators of the histamine h4 receptor
10/25/2012US20120270839 Compositions and methods for cancer treatment
10/24/2012EP2513115A1 Tricyclic antibiotics
10/24/2012EP2513113A1 5,5-fused arylene or heteroarylene hepatitis c virus inhibitors
10/24/2012EP2513108A1 Novel (heterocycle/condensed piperidine)-(piperazinyl)-1-alcanone or (heterocycle/condensed pyrrolidine)-(piperazinyl)-1-alcanone derivatives, and use thereof as p75 inhibitors
10/24/2012EP2513088A1 Novel (heterocycle/tetrahydropyridine)-(piperazinyl)-1-alcanone and (heterocycle/dihydropyrrolidine)-(piperazinyl)-1-alcanone derivatives, and use thereof as p75 inhibitors
10/24/2012EP2513083A1 Biphotonic photosensitizers, nanoparticles containing the same and their use as drugs
10/24/2012EP2512242A1 Novel compounds
10/24/2012EP2512238A1 Fused tricyclic compounds for the treatment of inflammatory disorders
10/24/2012CN102753557A Salt of fused heterocyclic derivative and crystal thereof
10/24/2012CN102753554A Raf inhibitor compounds and methods of use thereof
10/24/2012CN102746319A Preparation method of thienopyridine ketone compounds
10/24/2012CN102746318A Method for preparation of Prasugrel hydrochloride
10/24/2012CN102746225A Preparation method of 2-alkyl-3,4-disubstituted isoquinolyl-1(2H)-ketone derivative
10/24/2012CN102746224A Preparation method of 2-aryl-3,4-disubstituted isoquinolyl-1(2H)-ketone derivative
10/24/2012CN101282930B Fab I inhibitor and process for preparing same
10/23/2012US8293769 CSF-1R inhibitors, compositions, and methods of use
10/23/2012US8293754 Thienopyrimidine derivatives
10/23/2012CA2441410C Compounds and method of treatment having agonist-like activity selective at alpha 2b or 2b/2c adrenergic receptors
10/18/2012WO2012141197A1 Organic electroluminescence element
10/18/2012WO2012139422A1 Novel anti-platelet compound addition salt
10/18/2012US20120264900 Thienocoronene-imide semiconducting compounds and polymers
10/18/2012US20120264768 Bicyclic and tricyclic pyrimidine tyrosine kinase inhibitors with antitubulin activity and methods of treating a patient
1 ... 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 ... 214